The protective effects of cromakalim and pinacidil on reperfusion function and infarct size in isolated perfused rat hearts and anesthetized dogs
- 1 March 1990
- journal article
- conference paper
- Published by Springer Nature in Cardiovascular Drugs and Therapy
- Vol. 4 (2) , 465-474
- https://doi.org/10.1007/bf01857755
Abstract
The direct myocardial protective effects of intracoronary infusions of cromakalim and pinacidil were determined in an anesthetized canine model of coronary occlusion and reperfusion. The left circumflex coronary artery was occluded for 90 minutes and reperfused for 5 hours, at which time the infarct size was determined. Cromakalim (0.1 μg/kg/min) or pinacidil (0.09 μg/kg/min) were infused into the left circumflex coronary artery starting 10 minutes preischemia. Cromakalim significantly reduced infarct size as a percent of the left ventricular area at risk (25±5%) compared with vehicle controls (55±7%). Pinacidil did not reduce infarct size at an equimolar dose, but at the higher dose also significantly reduced infarct size. Collateral blood flow was not significantly altered by either drug, though reperfusion flow was significantly higher in cromakalim-treated animals, particularly in the subepicardial region. When the same dose of cromakalim was given starting 2 minutes before the initiation of reperfusion, no significant beneficial effect of cromakalim was observed. In another study, isolated buffer-perfused rat hearts were subjected to 25 minutes of global ischemia and 30 minutes of reperfusion. These hearts were treated with 7 μM cromakalim, either starting 10 minutes before ischemia or only during reperfusion, and its effect on reperfusion function and LDH release were determined. Cromakalim pretreatment (both when given throughout the experiment and when not present in the reperfusion buffer) resulted in significant improvements in the reperfusion function. Reperfusion contracture and LDH were also significantly reduced with this treatment. When given only during reperfusion, cromakalim did not reduce the severity of ischemia when compared with vehicle controls. Thus, both cromakalim and pinacidil reduce ischemic/reperfusion injury, though the timing of treatment may be important.Keywords
This publication has 32 references indexed in Scilit:
- Reduction of Size of Myocardial Infarction with Nicorandil, a New Antianginal Drug, After Coronary Artery Occlusion in DogsJournal of Cardiovascular Pharmacology, 1988
- Cromakalim, a Potassium Channel ActivatorJournal of Cardiovascular Pharmacology, 1988
- Is the Cardiovascular Profile of BRL 34915 Characteristic of Potassium Channel Activators?Journal of Cardiovascular Pharmacology, 1988
- The Relation Between Vascular Relaxant and Cardiac Electrophysiological Effects of PinacidilJournal of Cardiovascular Pharmacology, 1988
- Similarities in the Mechanism of Action of Two New Vasodilator Drugs: Pinacidil and BRL 34915Journal of Cardiovascular Pharmacology, 1988
- Effect of Intracoronary Diltiazem on ST-Segment Elevation and Myocardial Blood Flow During Pacing-Induced IschemiaJournal of Cardiovascular Pharmacology, 1987
- A low concentration of nisoldipine reduces ischemicheart injury: Enhanced reflow and recovery of contractile function without energy preservation during ischemiaJournal of Molecular and Cellular Cardiology, 1987
- BRL 34915, A Novel Antihypertensive Agent: Comparison of Effects on Blood Pressure and Other Haemodynamic Parameters with Those of Nifedipine in Animal ModelsJournal of Cardiovascular Pharmacology, 1987
- Effect of intracoronary verapamil on infarct size in the ischemic, reperfused canine heart: Critical importance of the timing of treatmentThe American Journal of Cardiology, 1985
- Effect of acute coronary artery occlusion on local myocardial extracellular K+ activity in swine.Circulation, 1980